113 related articles for article (PubMed ID: 29137236)
1. The nucleocytoplasmic translocation and up-regulation of ING5 protein in breast cancer: a potential target for gene therapy.
Ding XQ; Zhao S; Yang L; Zhao X; Zhao GF; Zhao SP; Li ZJ; Zheng HC
Oncotarget; 2017 Oct; 8(47):81953-81966. PubMed ID: 29137236
[TBL] [Abstract][Full Text] [Related]
2. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
3. [Nucleocytoplasmic translocation of ING5 protein in breast cancer and its correlation with poor clinicopathological characteristics of breast cancer].
Song Y; Zhao S; Qi F; Zheng H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jan; 34(1):53-58. PubMed ID: 29595458
[TBL] [Abstract][Full Text] [Related]
4. The roles of ING5 expression in ovarian carcinogenesis and subsequent progression: a target of gene therapy.
Zheng HC; Zhao S; Song Y; Ding XQ
Oncotarget; 2017 Nov; 8(61):103449-103464. PubMed ID: 29262575
[TBL] [Abstract][Full Text] [Related]
5. The down-regulated ING5 expression in lung cancer: a potential target of gene therapy.
Zhao S; Yang XF; Shen DF; Gao Y; Shi S; Wu JC; Liu HX; Sun HZ; Su RJ; Zheng HC
Oncotarget; 2016 Aug; 7(34):54596-54615. PubMed ID: 27409347
[TBL] [Abstract][Full Text] [Related]
6. The roles of ING5 in gliomas: a good marker for tumorigenesis and a potential target for gene therapy.
Zhao S; Zhao ZJ; He HY; Wu JC; Ding XQ; Yang L; Jia N; Li ZJ; Zheng HC
Oncotarget; 2017 Aug; 8(34):56558-56568. PubMed ID: 28915612
[TBL] [Abstract][Full Text] [Related]
7. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer.
Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T
Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545
[TBL] [Abstract][Full Text] [Related]
8. The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression.
Xing YN; Yang X; Xu XY; Zheng Y; Xu HM; Takano Y; Zheng HC
Hum Pathol; 2011 Jan; 42(1):25-35. PubMed ID: 21062663
[TBL] [Abstract][Full Text] [Related]
9. The roles of ING5 in cancer: A tumor suppressor.
Zheng HC; Xue H; Jiang HM
Front Cell Dev Biol; 2022; 10():1012179. PubMed ID: 36425530
[TBL] [Abstract][Full Text] [Related]
10. Decreased nuclear expression and increased cytoplasmic expression of ING5 may be linked to tumorigenesis and progression in human head and neck squamous cell carcinoma.
Li X; Nishida T; Noguchi A; Zheng Y; Takahashi H; Yang X; Masuda S; Takano Y
J Cancer Res Clin Oncol; 2010 Oct; 136(10):1573-83. PubMed ID: 20182888
[TBL] [Abstract][Full Text] [Related]
11. ING5 inhibits epithelial-mesenchymal transition in breast cancer by suppressing PI3K/Akt pathway.
Zhao QY; Ju F; Wang ZH; Ma XZ; Zhao H
Int J Clin Exp Med; 2015; 8(9):15498-505. PubMed ID: 26629040
[TBL] [Abstract][Full Text] [Related]
12. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
[TBL] [Abstract][Full Text] [Related]
13. ING5 knockdown enhances migration and invasion of lung cancer cells by inducing EMT via EGFR/PI3K/Akt and IL-6/STAT3 signaling pathways.
Liu XL; Zhang XT; Meng J; Zhang HF; Zhao Y; Li C; Sun Y; Mei QB; Zhang F; Zhang T
Oncotarget; 2017 Aug; 8(33):54265-54276. PubMed ID: 28903339
[TBL] [Abstract][Full Text] [Related]
14. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B
J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946
[TBL] [Abstract][Full Text] [Related]
15. The Roles of Beclin 1 Expression in Gastric Cancer: A Marker for Carcinogenesis, Aggressive Behaviors and Favorable Prognosis, and a Target of Gene Therapy.
Zheng HC; Zhao S; Xue H; Zhao EH; Jiang HM; Hao CL
Front Oncol; 2020; 10():613679. PubMed ID: 33425768
[TBL] [Abstract][Full Text] [Related]
16. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
17. ING5 inhibits cancer aggressiveness by inhibiting Akt and activating p53 in prostate cancer.
Barlak N; Capik O; Sanli F; Kilic A; Aytatli A; Yazici A; Ortucu S; Ittmann M; Karatas OF
Cell Biol Int; 2020 Jan; 44(1):242-252. PubMed ID: 31475765
[TBL] [Abstract][Full Text] [Related]
18. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
[TBL] [Abstract][Full Text] [Related]
19. The in vitro and vivo effects of nuclear and cytosolic parafibromin expression on the aggressive phenotypes of colorectal cancer cells: a search of potential gene therapy target.
Zheng HC; Liu JJ; Li J; Wu JC; Yang L; Zhao GF; Zhao X; Jiang HM; Huang KQ; Li ZJ
Oncotarget; 2017 Apr; 8(14):23603-23612. PubMed ID: 28223542
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional Regulation of ING5 and its Suppressive Effects on Gastric Cancer.
Zheng HC; Xue H; Wu X; Xu HL; Zhao EH; Cui ZG
Front Oncol; 2022; 12():918954. PubMed ID: 35747809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
